Press Releases
PLEASANTON, Calif., July 16, 2019 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics researchers the right tool for the job, launched the new
Read more...16 July 2019
ROCKVILLE, Md., July 16, 2019 /PRNewswire/ -- RRD International, a specialized product development company that provides strategic and operational support to biopharmaceutical companies and investors, today announced the appointment of Nigel Thomas, PhD as senior vice president development operations. Dr. Thomas has spent the last 25 years
Read more...PORT WASHINGTON, N.Y., July 16, 2019 /PRNewswire/ -- Pall Corporation, a global leader in filtration, separation and purification, has been chosen by Servier, an independent international pharmaceutical
Read more...Skyhawk will use its SkySTARTM platform to develop drug candidates directed to multiple targets for oncology and neurodegenerative diseases. In exchange Skyhawk will receive an upfront payment and may be eligible for more than $2 billion over time, including opt-in fees and milestone payments plus royalties on sales of commercialized medicines.
Read more...16 July 2019
LAUREL, Md., July 16, 2019 /PRNewswire/ -- Maryland University of Integrative Health (MUIH) is proud to announce that internationally recognized Chinese medicine practitioner and scholar Dr. Paul Unschuld will speak on the Líng Shū 靈樞, Běn Cǎo Gāng Mù 本草綱目, and
Read more...16 July 2019
LOVELAND, Colo., July 16, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to report its second quarter 2019 financial performance in a press release on Tuesday, August 6, 2019 before the market opens and to host an earnings call
Read more...BUFFALO, N.Y., July 16, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announces a
Read more...SAN DIEGO, July 16, 2019 /PRNewswire/ -- Ambrx Inc. today announced that Bristol-Myers Squibb Company ("BMS") has initiated a phase I clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of long-acting Relaxin for the potential treatment of heart failure ("HF"). Long-acting Relaxin is an investigational biologic produced using Ambrx' pro
Read more...16 July 2019
FORT LAUDERDALE, Fla., July 16, 2019 /PRNewswire/ -- With locations in both Plantation and Fort Lauderdale Florida, South Florida Sinus and Allergy Center provides expert care and treatment for those patients suffering from sinus, allergy, snoring, and sleep disorders.
Read more...OMAHA, Neb., July 16, 2019 /PRNewswire/ -- REAL Radiology, LLC (NE) is setting the standard for sustainable growth and continued patient-care excellence in the high-demand industry of teleradiology.The global teleradiology market is predicted to reach an all-time high both in market value and demand, according to a recently published
Read more...